Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 New osteoporosis guidelines for Canada.

Literature DB >> 20940235

New osteoporosis guidelines for Canada.

John A Kanis¹.

Abstract

Entities: Disease

Mesh：

Year: 2010 PMID： 20940235 PMCID： PMC2988527 DOI： 10.1503/cmaj.101438

Source DB: PubMed Journal: CMAJ ISSN： 0820-3946 Impact factor: 8.262

× No keyword cloud information.

8 in total

1. 2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary.

Authors: Alexandra Papaioannou; Suzanne Morin; Angela M Cheung; Stephanie Atkinson; Jacques P Brown; Sidney Feldman; David A Hanley; Anthony Hodsman; Sophie A Jamal; Stephanie M Kaiser; Brent Kvern; Kerry Siminoski; William D Leslie
Journal: CMAJ Date: 2010-10-12 Impact factor: 8.262

2. Compliance with osteoporosis therapy is the weakest link.

Authors: Juliet E Compston; Ego Seeman
Journal: Lancet Date: 2006-09-16 Impact factor: 79.321

3. Recommendations for bone mineral density reporting in Canada.

Authors: Kerry Siminoski; William D Leslie; Heather Frame; Anthony Hodsman; Robert G Josse; Aliya Khan; Brian C Lentle; Jacques Lévesque; David J Lyons; Giuseppe Tarulli; Jacques P Brown
Journal: Can Assoc Radiol J Date: 2005-06 Impact factor: 2.248

Review 4. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group.

Authors:
Journal: World Health Organ Tech Rep Ser Date: 1994

Review 5. 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada.

Authors: Jacques P Brown; Robert G Josse
Journal: CMAJ Date: 2002-11-12 Impact factor: 8.262

6. Independent clinical validation of a Canadian FRAX tool: fracture prediction and model calibration.

Authors: William D Leslie; Lisa M Lix; Helena Johansson; Anders Oden; Eugene McCloskey; John A Kanis
Journal: J Bone Miner Res Date: 2010-11 Impact factor: 6.741

7. Cost-effective osteoporosis treatment thresholds: the United States perspective.

Authors: A N A Tosteson; L J Melton; B Dawson-Hughes; S Baim; M J Favus; S Khosla; R L Lindsay
Journal: Osteoporos Int Date: 2008-02-22 Impact factor: 4.507

Review 8. The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women.

Authors: J A Kanis; A Oden; O Johnell; H Johansson; C De Laet; J Brown; P Burckhardt; C Cooper; C Christiansen; S Cummings; J A Eisman; S Fujiwara; C Glüer; D Goltzman; D Hans; M-A Krieg; A La Croix; E McCloskey; D Mellstrom; L J Melton; H Pols; J Reeve; K Sanders; A-M Schott; A Silman; D Torgerson; T van Staa; N B Watts; N Yoshimura
Journal: Osteoporos Int Date: 2007-02-24 Impact factor: 4.507

8 in total

4 in total

New osteoporosis guidelines for Canada.

1. 2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary.

2. Compliance with osteoporosis therapy is the weakest link.

3. Recommendations for bone mineral density reporting in Canada.

Review 4. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group.

Review 5. 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada.

6. Independent clinical validation of a Canadian FRAX tool: fracture prediction and model calibration.

7. Cost-effective osteoporosis treatment thresholds: the United States perspective.

Review 8. The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women.

1. Bones and groans.

2. [Co-management in geriatric traumatology].

Review 3. [Proximal femoral fractures in the elderly].

Review 4. [Augmentation techniques on the proximal femur].